摘要
目的:总结46例急性早幼粒细胞白血病(APL)的治疗、预后及不良反应,以达到提高缓解率,延长生存期的目的。方法:对46例APL患者治疗期间应用全反式维甲酸、亚砷酸、DA/MA/HA及复方黄黛片进行联合治疗。结果:本组46例APL患者除2例早期死亡外,其余44例均达到完全缓解(CR),CR率为95.7%。结论:应用全反式维甲酸、亚砷酸及复方黄黛片联合治疗APL是安全有效的,对初治或复发患者均具有疗效高、耐受性好的特点。
Objective:To review the treatment,prognosis and adverse reaction in 46 cases of acute promyelocytic leukemia(APL),leading to alleviation rate increased and lifetime prolonged.Methods:Treat 46 cases of APL patients with all-trans retinoic acid,arsenious acid,DA/MA/HA and compound Huangdai tablet.Results: 44 patients reached complete remission(CR),except 2 cases of early death.CR rate was 95.7%.Conclusion:It is safe and effective with combination therapy of all-trans retinoic acid,arsenious acid and compound huangdai Tablet for APL patients.It has high efficacy and good tolerability for the first diagnosed and relapsed patients.
出处
《中国当代医药》
2010年第22期20-21,共2页
China Modern Medicine
关键词
白血病
早幼粒细胞
急性
治疗结果
亚砷酸类
疗效分析
Leukemia
Promyelocytic
Acute
Treatment outcome
Arsenious acid type
Effectiveness analysis